ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$6.46
-25.94%
Mkt Cap $9.15B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+85.9%
Consensus $12.00 vs current $6.46
NASDAQ·Healthcare·Biotechnology
$6.46
-25.94%
Mkt Cap $9.15B
Buy
5
Hold
0
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
+85.9%
Consensus $12.00 vs current $6.46